http://ift.tt/eA8V8J
The drugmaker says it incorrectly classified royalties from the Tysabri drug as an intangible asset rather than a financial asset.
April 26, 2017 at 11:38PM
from Matthew Heller
http://ift.tt/eA8V8J
The drugmaker says it incorrectly classified royalties from the Tysabri drug as an intangible asset rather than a financial asset.
April 26, 2017 at 11:38PM
from Matthew Heller
No comments:
Post a Comment